drugset / Trial / NCT02916238

Measurement-based Care for Depression in Resource-Poor Settings

NCT02916238

Phase 4 Completed 140 enrolled Florida International University
RandomizedParallel-groupOpen-labelTreatment

Summary

Depression is often the most prevalent mental health problem among people living with HIV (PLWH) worldwide, and if not adequately treated, it may impair response to antiretroviral treatment (ART) and the ability of individuals to adhere to medications and healthy behavior. Most patients with depression receiving ART in the poorest countries of the world are left untreated because no systematic approach or expertise is available. This study adapts an evidence-based model of depression care (Measurement-Based Care - MBC) using auxiliary HIV clinic staff, and tests feasibility and assesses costs among HIV positive patients beginning ART in Port-au-Prince, Haiti.

Timeline

Start
2014-02
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 60 mg